CD18 antigen is the beta chain of lymphocyte integrins. It is covalently attached to CD11a, CD11b, and Cd11c and is strongly expressed on all types of leukocytes.
| Inventor | Institute |
|---|---|
| Francisco Ruíz-Cabello Osuna, Miguel Ángel López-Nevot, Federico Garrido Torres-Puchol, Susana Pedrinaci Rodriguez | Virgen de las Nieves University Hospital, The Andalusian Health Service |
| SKU: | 161693 |
|---|---|
| Product description: | CD18 antigen is the beta chain of lymphocyte integrins. It is covalently attached to CD11a, CD11b, and Cd11c and is strongly expressed on all types of leukocytes. |
| Isotype: | IgG1k |
| Molecular weight: | 95 kDa |
| Immunogen: | U937 cell line |
| Cat. #: | 161693 |
|---|---|
| Tool sub type: | Primary antibody |
| Research Fields: | Cell biology; Cell signaling and signal transduction; Immunophenotyping; Stem cell biology |
| Application: | FACS; IHC; ELISA; WB |
| Target: | CD18 |
| Reactivity: | Human |
| Clone: | GRF1 |
| Host: | Mouse |
| Class: | Monoclonal |
| Primary citation: | Pedrinaci et al. 1989. Hybridoma. 8(1):13-23. PMID: 2564369 |
| Storage buffer: | PBS with 0.02% azide |
|---|---|
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Pedrinaci et al. 1989. Hybridoma. 8(1):13-23. PMID: 2564369 |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151029 | Anti-HSVICP8 [11E2] |
Key Info
Anti-HSVICP8 [11E2]
|
View Tool | |||||||||||||||||||
| 151015 | Anti-CyclinA [E70.1] |
Key Info
Anti-CyclinA [E70.1]
|
View Tool | |||||||||||||||||||
| 151018 | Anti-Mos [R38.1] |
Key Info
Anti-Mos [R38.1]
|
View Tool | |||||||||||||||||||
| 151023 | Anti-IL12 [1-1D5] |
Key Info
Anti-IL12 [1-1D5]
|
View Tool | |||||||||||||||||||
| 151039 | Anti-Integrin aVb3 [23C6] |
Key Info
Anti-Integrin aVb3 [23C6]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.